NCT04826731View on ClinicalTrials.gov

Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 1, 2021

Study Completion Date

July 1, 2021

Conditions
Covid19Respiratory Function LossCoronavirus InfectionPneumonia, Viral
Interventions
OTHER

Incentive Spirometer/Respiratory Exerciser

"A patient is considered acceptable for the Incentive Spirometer Group if the patient can use an incentive spirometer and/or a respiratory exerciser at least four times per day. A pulmonary medicine specialist will confirm the proper usage of the device."

Trial Locations (1)

06110

Dışkapı Yıldırım Beyazıt Training and Research Hospital Pulmonary Medicine Clinic, Ankara

All Listed Sponsors
lead

Diskapi Yildirim Beyazit Education and Research Hospital

OTHER_GOV

NCT04826731 - Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients | Biotech Hunter | Biotech Hunter